DIEGO
RINCÓN RODRÍGUEZ
Profesor asociado de Ciencias de la Salud
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (32)
2024
-
Hepatic hemodynamic study: More than just HVPG measurement
Gastroenterologia y Hepatologia
2023
2022
-
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818
-
Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study
European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412
-
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history
United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816
-
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310
2021
-
HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation
Transplant International, Vol. 34, Núm. 11, pp. 2214-2225
-
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033
-
Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients
Therapeutic Advances in Gastroenterology, Vol. 14
2020
-
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
Hepatology, Vol. 72, Núm. 6, pp. 1924-1934
2019
-
Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients
Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186
-
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain
PLoS ONE, Vol. 14, Núm. 11
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
Journal of Viral Hepatitis, Vol. 24, Núm. 4, pp. 304-311
-
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Journal of Hepatology, Vol. 66, Núm. 6, pp. 1138-1148
-
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Clinical Gastroenterology and Hepatology, Vol. 15, Núm. 6, pp. 945-949.e1
-
Real-world multicenter experience of immunosuppression minimization among 661 liver transplant recipients
Annals of Transplantation, Vol. 22, pp. 265-275
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation
Therapeutic Apheresis and Dialysis, Vol. 20, Núm. 2, pp. 189-196